Comparative treatment effectiveness of oral fingolimod and conventional injectable disease‐modifying agents in multiple sclerosis

2021 ◽  
Author(s):  
Jagadeswara R. Earla ◽  
George J. Hutton ◽  
Douglas J. Thornton ◽  
Hua Chen ◽  
Michael L. Johnson ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Treatment Effectiveness ◽  
Comparative Treatment ◽  
Disease Modifying ◽  
Disease Modifying Agents

scholarly journals Quality of life for veterans with multiple sclerosis on disease-modifying agents: Relationship to disability

2006 ◽  
Vol 43 (1) ◽  
pp. 35 ◽  
Author(s):  
Joseph B. Guarnaccia ◽  
Mihaela Aslan ◽  
Theresa Z. OConnor ◽  
MaryAnn Hope ◽  
Lewis Kazis ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Multiple Sclerosis ◽  
Disease Modifying ◽  
Disease Modifying Agents

Use of disease modifying agents in patients with multiple sclerosis: Analysis of ten years of national data

2020 ◽  
Vol 16 (12) ◽  
pp. 1670-1676
Author(s):  
Jagadeswara R. Earla ◽  
Rutugandha Paranjpe ◽  
Nandita Kachru ◽  
George J. Hutton ◽  
Rajender R. Aparasu
Keyword(s):  
Multiple Sclerosis ◽  
National Data ◽  
Disease Modifying ◽  
Disease Modifying Agents

Prescribing of Disease Modifying Agents in Older Adults with Multiple Sclerosis

2021 ◽  
pp. 103308
Author(s):  
Ashna Talwar ◽  
Jagadeswara R. Earla ◽  
George J. Hutton ◽  
Rajender R. Aparasu
Keyword(s):  
Multiple Sclerosis ◽  
Older Adults ◽  
Disease Modifying ◽  
Disease Modifying Agents

Observe and Accept: A Pathways Approach to Multiple Sclerosis

Biofeedback ◽  
2019 ◽  
Vol 47 (3) ◽  
pp. 71-78
Author(s):  
Donald Moss
Keyword(s):  
Multiple Sclerosis ◽  
Complementary Therapies ◽  
Nutritional Supplements ◽  
Biofeedback Training ◽  
Depression And Anxiety ◽  
Blurred Vision ◽  
Mindfulness Skills ◽  
The Central Nervous System ◽  
Disease Modifying ◽  
Disease Modifying Agents

Multiple sclerosis (MS) is a chronic disease, marked by demyelination of the central nervous system and a wide variety of symptoms, including blurred vision, muscle weakness, and impaired motor control, most of which occur in a remitting and relapsing pattern. In many cases the illness is progressive with severe disability. Current treatments combine interventions to manage the current episode and disease-modifying agents to reduce the risk of further episodes. The treatments for MS are only partially effective, and patients often face a confusing and frightening progression of their illness, despite treatment. Many patients utilize complementary therapies, especially dietary changes, nutritional supplements, and relaxation skills. This article presents the case narrative of a 36-year-old woman who was referred for depression and anxiety accompanying a 3-year period of recurring MS episodes. She combined many complementary therapies along with the medical management of her illness, and benefitted especially from mindfulness skills and biofeedback training.

Sign in / Sign up

Export Citation Format

Share Document